首页> 外文期刊>Thoracic cancer. >Downregulation of lncRNA‐HEIH curbs esophageal squamous cell carcinoma progression by modulating miR ‐4458/ PBX3
【24h】

Downregulation of lncRNA‐HEIH curbs esophageal squamous cell carcinoma progression by modulating miR ‐4458/ PBX3

机译:通过调节MiR -4458 / PBX3,下调LNCRNA-Heih静脉抑制食管鳞状细胞癌进展

获取原文
           

摘要

BACKGROUND:Long non-coding RNAs (lncRNAs) have been found to play a specific part in the development of esophageal squamous cell carcinoma (ESCC), except for lncRNA HEIH. Here, we aimed to discover the molecular mechanisms of HEIH in ESCC.METHODS:We detected the expression level of HEIH and miR-4458 in ESCC tissues and cells using qRT-PCR assay. A dual luciferase reporter assay was used to check the relationship between HEIH, miR-4458 or PBX3. Counting Clock Kit-8 (CCK-8) assay and transwell assay were used to detect ESCC cell proliferation and invasion capability. Western blot analysis was used to measure the protein expression level of PBX3.RESULTS:HEIH was confirmed to be upregulated in both ESCC tissues and cell lines. Inversely, there was a downregulation of miR-4458 in ESCC tissues and cell lines. Functionally, we noticed that depletion of HEIH restrained ESCC cell viability, and invasion capability. Moreover, PBX silencing was found to restrain ESCC cell progression, while miR-4458 or HEIH vector both could alleviate its suppressive effect.CONCLUSIONS:The present study clarified that HEIH regulated ESCC progression by suppressing miR-4458 and upregulating PBX3. Our findings suggested that HEIH could be a possible therapeutic target for ESCC treatment.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:背景:已发现长期非编码RNA(LNCRNA)在食管鳞状细胞癌(ESCC)的发育中发挥特定部分,除了LNCRNA Heih。在这里,我们旨在发现Heih在ESCC的分子机制。使用QRT-PCR测定,我们在ESCC组织和细胞中检测到Heih和miR-4458的表达水平。使用双荧光素酶报告器测定检查Heih,miR-4458或pbx3之间的关系。计数时钟套件-8(CCK-8)测定和Transwell测定用于检测ESCC细胞增殖和侵袭能力。 Western印迹分析用于测量PBX3的蛋白质表达水平。结果:确认HeiH被证实在两个ESCC组织和细胞系中上调。相反,在ESCC组织和细胞系中有MIR-4458的下调。在功能上,我们注意到Heih的耗尽限制了ESCC细胞活力和侵袭能力。此外,发现PBX沉默抑制ESCC细胞进展,而MiR-4458或HeiH载体均可缓解其抑制作用。结论:本研究通过抑制miR-4458并上调PBX3,阐明了Heih调节的ESCC进展。我们的研究结果表明,Heih可以成为ESCC治疗的可能治疗目标。 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号